Cambridge Investment Research Advisors, Inc. Guardant Health, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 12,239 shares of GH stock, worth $859,177. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,239
Previous 12,554
2.51%
Holding current value
$859,177
Previous $535,000
19.07%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding GH
# of Institutions
421Shares Held
125MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$854 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$789 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$349 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$338 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$298 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $7.18B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...